Compare TSCO & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSCO | GEHC |
|---|---|---|
| Founded | 1938 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.6B | 33.1B |
| IPO Year | 1994 | N/A |
| Metric | TSCO | GEHC |
|---|---|---|
| Price | $52.27 | $83.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 9 |
| Target Price | $63.10 | ★ $86.67 |
| AVG Volume (30 Days) | ★ 5.5M | 4.1M |
| Earning Date | 01-29-2026 | 10-29-2025 |
| Dividend Yield | ★ 1.72% | 0.17% |
| EPS Growth | 0.57 | ★ 32.35 |
| EPS | 2.07 | ★ 4.83 |
| Revenue | $15,399,257,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $7.32 | $6.33 |
| Revenue Next Year | $6.54 | $4.38 |
| P/E Ratio | $25.85 | ★ $17.05 |
| Revenue Growth | ★ 4.26 | 3.51 |
| 52 Week Low | $46.85 | $57.65 |
| 52 Week High | $63.99 | $94.80 |
| Indicator | TSCO | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 57.70 |
| Support Level | $51.55 | $81.74 |
| Resistance Level | $53.73 | $86.19 |
| Average True Range (ATR) | 1.13 | 2.12 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 20.97 | 58.21 |
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,335 of its namesake banners in 49 states, along with 207 Petsense by Tractor Supply stores. Stores are generally concentrated in rural communities rather than urban and suburban areas. In fiscal 2024, revenue consisted primarily of livestock, equine & agriculture (26%), companion animal (25%), and seasonal & recreation (23%).
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).